ID Title Authors Journal Publication Year DOI
3. Target identification of drug induced mitochondrial toxicity using immunocapture based OXPHOS activity assays. Nadanaciva, Sashi; Bernal, Autumn; Aggeler, Robert; Capaldi, Roderick; Will, Yvonne Toxicology in Vitro 2007 10.1016/j.tiv.2007.01.011
249. Glycolysis inhibition for anticancer treatment. Pelicano, H; Martin, D S; Xu, R-H; Huang, P Oncogene 2006 10.1038/sj.onc.1209597
281. Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones. McKee, E E; Ferguson, M; Bentley, A T; Marks, T A Antimicrobial Agents and Chemotherapy 2006 10.1128/AAC.01411-05
20. Effect of the anti-anginal agent, perhexiline, on neutrophil, valvular and vascular superoxide formation. Kennedy, Jennifer A; Beck-Oldach, Konstanz; McFadden-Lewis, Kate; Murphy, Geraldine A; Wong, Yee W; Zhang, Yi; Horowitz, John D European Journal of Pharmacology 2006 10.1016/j.ejphar.2005.11.058
229. Mitochondrial thioredoxin in regulation of oxidant-induced cell death. Chen, Yan; Cai, Jiyang; Jones, Dean P FEBS Letters 2006 10.1016/j.febslet.2006.11.007
41. Bioactivation and hepatotoxicity of nitroaromatic drugs. Boelsterli, Urs A; Ho, Han Kiat; Zhou, Shufeng; Leow, Koon Yeow Current Drug Metabolism 2006 10.2174/138920006778520606
10. Mefloquine selectively increases asynchronous acetylcholine release from motor nerve terminals. McArdle, Joseph J; Sellin, Lawrence C; Coakley, Kathleen M; Potian, Joseph G; Hognason, Kormakur Neuropharmacology 2006 10.1016/j.neuropharm.2005.09.011
72. Structural and computational analysis of the quinone-binding site of complex II (succinate-ubiquinone oxidoreductase): a mechanism of electron transfer and proton conduction during ubiquinone reduction. Horsefield, Rob; Yankovskaya, Victoria; Sexton, Graham; Whittingham, William; Shiomi, Kazuro; Omura, Satoshi; Byrne, Bernadette; Cecchini, Gary; Iwata, So The Journal of Biological Chemistry 2006 10.1074/jbc.M508173200
331. Mitochondrial permeability transition as a potential determinant of hepatotoxicity of antidiabetic thiazolidinediones. Masubuchi, Yasuhiro; Kano, Satomi; Horie, Toshiharu Toxicology 2006 10.1016/j.tox.2006.02.017
209. The anti-inflammatory drug, nimesulide (4-nitro-2-phenoxymethane-sulfoanilide), uncouples mitochondria and induces mitochondrial permeability transition in human hepatoma cells: protection by albumin. Berson, Alain; Cazanave, Sophie; Descatoire, V?ronique; Tinel, Marina; Grodet, Alain; Wolf, Claude; Feldmann, G?rard; Pessayre, Dominique The Journal of Pharmacology and Experimental Therapeutics 2006 10.1124/jpet.106.104125
211. Mitochondrial Toxicity Associated with Linezolid Soriano, Alex; Mir?, Oscar; Mensa, Josep The New England Journal of Medicine 2005 10.1056/NEJM200511243532123
289. Inhibition of MG132-induced mitochondrial dysfunction and cell death in PC12 cells by 3-morpholinosydnonimine. Lee, Chung Soo; Han, Eun Sook; Park, Eon Sob; Bang, Hyoweon Brain Research 2005 10.1016/j.brainres.2004.12.036
4. Mechanisms of benzarone and benzbromarone-induced hepatic toxicity. Kaufmann, Priska; Török, Michael; Hänni, Anya; Roberts, Paul; Gasser, Rodolfo; Krähenbühl, Stephan Hepatology 2005 10.1002/hep.20634
282. Oxazolidinones inhibit cellular proliferation via inhibition of mitochondrial protein synthesis. Nagiec, Eva E; Wu, Luping; Swaney, Steve M; Chosay, John G; Ross, Daniel E; Brieland, Joan K; Leach, Karen L Antimicrobial Agents and Chemotherapy 2005 10.1128/AAC.49.9.3896-3902.2005
82. Mechanistic differences in inhibition of ubiquinol cytochrome c reductase by the proximal Qo-site inhibitors famoxadone and methoxyacrylate stilbene. Pember, Stephen O; Fleck, Lois C; Moberg, William K; Walker, Michael P Archives of Biochemistry and Biophysics 2005 10.1016/j.abb.2004.12.013
57. Release of cytochrome c from isolated mitochondria by etoposide. Park, Jung-Hee; Kim, Tae-Hyoung Journal of Biochemistry and Molecular Biology 2005 10.5483/bmbrep.2005.38.5.619
70. A possible site of superoxide generation in the complex I segment of rat heart mitochondria. Ohnishi, S Tsuyoshi; Ohnishi, Tomoko; Muranaka, Shikibu; Fujita, Hirofumi; Kimura, Hiroko; Uemura, Koichi; Yoshida, Ken-ichi; Utsumi, Kozo Journal of Bioenergetics and Biomembranes 2005 10.1007/s10863-005-4117-y
142. Inhibition sites in F1-ATPase from bovine heart mitochondria. Gledhill, Jonathan R; Walker, John E The Biochemical Journal 2005 10.1042/BJ20041513
185. Drug-induced mitochondrial toxicity. Chan, Katie; Truong, Don; Shangari, Nandita; O'Brien, Peter J Expert Opinion on Drug Metabolism & Toxicology 2005 10.1517/17425255.1.4.655
189. 5-Hydroxydecanoate is metabolised in mitochondria and creates a rate-limiting bottleneck for beta-oxidation of fatty acids. Hanley, Peter J; Dr?se, Stefan; Brandt, Ulrich; Lareau, Rachel A; Banerjee, Abir L; Srivastava, D K; Banaszak, Leonard J; Barycki, Joseph J; Van Veldhoven, Paul P; Daut, J?rgen The Journal of Physiology 2005 10.1113/jphysiol.2004.073932
330. Troglitazone induces a rapid drop of mitochondrial membrane potential in liver HepG2 cells. Bova, Michael P; Tam, Danny; McMahon, Gerald; Mattson, Matthew N Toxicology Letters 2005 10.1016/j.toxlet.2004.08.009
262. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells. Fujie, Yujiro; Yamamoto, Hirofumi; Ngan, Chew Yee; Takagi, Akimitsu; Hayashi, Taro; Suzuki, Rei; Ezumi, Koji; Takemasa, Ichiro; Ikeda, Masataka; Sekimoto, Mitsugu; Matsuura, Nariaki; Monden, Morito Japanese journal of clinical oncology 2005 10.1093/jjco/hyi130
258. Acetaminophen induced hepatotoxicity: role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition Hinson, Jack A.; Reid, Angela B.; McCullough, Sandra S.; James, Laura P. Drug Metabolism Reviews 2004 10.1081/DMR-200033494
17. Metabolic manipulation in ischaemic heart disease, a novel approach to treatment. Lee, Leong; Horowitz, John; Frenneaux, Michael European Heart Journal 2004 10.1016/j.ehj.2004.02.018
83. Crystallographic studies of quinol oxidation site inhibitors: a modified classification of inhibitors for the cytochrome bc(1) complex. Esser, Lothar; Quinn, Byron; Li, Yong-Fu; Zhang, Minquan; Elberry, Maria; Yu, Linda; Yu, Chang-An; Xia, Di Journal of Molecular Biology 2004 10.1016/j.jmb.2004.05.065
285. Human mitochondrial complex I assembles through the combination of evolutionary conserved modules: a framework to interpret complex I deficiencies. Ugalde, Cristina; Vogel, Rutger; Huijbens, Richard; Van Den Heuvel, Bert; Smeitink, Jan; Nijtmans, Leo Human Molecular Genetics 2004 10.1093/hmg/ddh262
219. Axonal mitochondrial transport and potential are correlated. Miller, Kyle E; Sheetz, Michael P Journal of Cell Science 2004 10.1242/jcs.01130
47. Measurement of oxygen consumption in mouse aortic endothelial cells using a microparticulate oximetry probe. Pandian, Ramasamy P; Kutala, Vijay Kumar; Parinandi, Narasimham L; Zweier, Jay L; Kuppusamy, Periannan Archives of Biochemistry and Biophysics 2003 10.1016/j.abb.2003.09.008
23. Differential effects of typical and atypical neuroleptics on mitochondrial function in vitro. Modica-Napolitano, Josephine S; Lagace, Christopher J; Brennan, William A; Aprille, June R Archives of Pharmacal Research 2003 10.1007/bf02980205
68. Tacrolimus and sirolimus decrease oxidative phosphorylation of isolated rat kidney mitochondria. Simon, Nicolas; Morin, Christophe; Urien, Saïk; Tillement, Jean-Paul; Bruguerolle, Bernard British Journal of Pharmacology 2003 10.1038/sj.bjp.0705038